Thermo Fisher licenses CRISPR tech from Broad Institute

In a move to expand its genome editing IP portfolio, Thermo Fisher has picked up a license for CRISPR technologies from the Broad Institute of MIT and Harvard and ERS Genomics. This builds on previous CRISPR license agreements with ToolGen.